• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Etravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced fibrosis patients receiving triple therapy against hepatitis C virus with telaprevir.

作者信息

Ramirez Maria Luisa Montes, Vargas Francisco X Zamora, González-Garcia Juan, Quereda Carmen, Pérez-Elías Maria Jesús, de Cea Alvaro Mena, Barros Carlos, Condés Emilia, Moreno Jose Sanz, Santos Ignacio, Torralba Miguel, Aldamiz-Echevarria Teresa, Moreno Ana

机构信息

aHospital Universitario La Paz, Madrid bHospital Ramón y Cajal, Madrid cComplexo Hospitalario Universitario de A Coruña, Madrid dHospital de Móstoles, Madrid eFacultad de ciencias Biomédicas, Especialidades Médicas, Psicología y Pedagogía Aplicadas, Universidad Europea, Madrid fHospital Universitario Príncipe de Asturias, Madrid gHospital Universitario La Princesa, Madrid hHospital Universitario Guadalajara, Madrid iHospital Universitario Gregorio Marañón, Madrid, Spain.

出版信息

AIDS. 2014 Oct 23;28(16):2487-9. doi: 10.1097/QAD.0000000000000425.

DOI:10.1097/QAD.0000000000000425
PMID:25265233
Abstract
摘要

相似文献

1
Etravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced fibrosis patients receiving triple therapy against hepatitis C virus with telaprevir.基于依曲韦林的抗逆转录病毒疗法用于接受特拉匹韦三联疗法治疗丙型肝炎病毒的HIV/丙型肝炎病毒合并感染的晚期纤维化患者。
AIDS. 2014 Oct 23;28(16):2487-9. doi: 10.1097/QAD.0000000000000425.
2
Telaprevir decreases estimated glomerular filtration rate in HIV-hepatitis C virus coinfected patients.
AIDS. 2015 May 15;29(8):977-9. doi: 10.1097/QAD.0000000000000643.
3
Pharmacokinetic interactions between telaprevir and antiretroviral drugs in HIV/HCV-coinfected patients with advanced liver fibrosis and prior HCV non-responders.Telaprevir 与抗逆转录病毒药物在伴有晚期肝纤维化和既往 HCV 无应答的 HIV/HCV 合并感染患者中的药代动力学相互作用。
Int J Antimicrob Agents. 2015 May;45(5):545-9. doi: 10.1016/j.ijantimicag.2014.12.035. Epub 2015 Feb 21.
4
Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV-HCV coinfected subjects.特拉匹韦、聚乙二醇化干扰素和利巴韦林治疗肝硬化HIV-HCV合并感染患者24周后的疗效和耐受性。
Antiviral Res. 2014 Apr;104:59-61. doi: 10.1016/j.antiviral.2014.01.019. Epub 2014 Jan 31.
5
[Prevalence of potential interactions between antiretroviral therapy and boceprevir or telaprevir in human immunodeficiency virus-hepatitis C virus coinfected patients].[抗逆转录病毒疗法与博赛泼维或特拉泼维在人类免疫缺陷病毒-丙型肝炎病毒合并感染患者中潜在相互作用的患病率]
Enferm Infecc Microbiol Clin. 2013 May;31(5):350-1. doi: 10.1016/j.eimc.2012.09.016. Epub 2012 Nov 23.
6
Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients.导入水飞蓟宾及后续三联疗法对难治性HIV/丙型肝炎病毒合并感染患者的疗效
HIV Med. 2014 Nov;15(10):625-30. doi: 10.1111/hiv.12166. Epub 2014 Jun 4.
7
High incidence of serious adverse events in HIV-infected patients treated with a telaprevir-based hepatitis C virus treatment regimen.接受基于替拉瑞韦的丙型肝炎病毒治疗方案治疗的HIV感染患者中严重不良事件的高发生率。
AIDS. 2013 Nov 28;27(18):2893-7. doi: 10.1097/01.aids.0000432466.15885.14.
8
Darunavir and telaprevir drug interaction: total and unbound plasma concentrations in HIV/HCV-coinfected patients with cirrhosis.达芦那韦与特拉匹韦的药物相互作用：合并感染HIV/HCV的肝硬化患者的血浆总浓度与游离浓度
J Antimicrob Chemother. 2014 May;69(5):1434-6. doi: 10.1093/jac/dkt509. Epub 2013 Dec 19.
9
Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.抗逆转录病毒治疗（HAART）暴露及相关脂肪营养不良对 HIV/HCV 合并感染患者晚期肝纤维化的影响。
J Viral Hepat. 2011 Jul;18(7):e307-14. doi: 10.1111/j.1365-2893.2010.01417.x. Epub 2011 Jan 11.
10
Challenges in the treatment of chronic hepatitis C in the HIV/HCV-coinfected patient.慢性丙型肝炎合并 HIV 感染患者的治疗挑战。
Expert Rev Anti Infect Ther. 2012 Oct;10(10):1117-28. doi: 10.1586/eri.12.107.

引用本文的文献

1
NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved.NNRTI 与肝损伤：关联证据及相关机制。
Cells. 2021 Jul 4;10(7):1687. doi: 10.3390/cells10071687.